India’s highest drug controller, Central Drug Control Standard Organisation , has approved the emergency use of Remdesivir on COVID-19 patients, saying it reduces replication of the virus in the body.
It said: “Remdesivir will be available in the form of an injection and will only be sold on retail by the prescription of a doctor for hospital use. The drug has been shown to reduce replication of COVID-19 in the body system.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Council issues guidelines for private laboratories to conduct COVID-19 test“For these private medical laboratories, providing a public sector function, NCDC and its partners will continue to support the provision of reagents and consumables so that testing is conducted at no cost to the patient.” Nigeria Covid19 Nigerians stranded in India need your help! They have spent a lot of money for their evacuation but denied access home severally due to recurrent cancellation of scheduled flight with Airpeace. Majority are patients and students. Look into this as a matter of urgency! The issue still on going?
Source: GuardianNigeria - 🏆 1. / 94 Read more »
COVID-19: NCDC commends Obaseki’s responseThe Director-General of Nigeria Centre for Disease Control (NCDC), Dr. Chikwe Ihekweazu, has applauded the Governor Godwin Obaseki-led..
Source: TheNationNews - 🏆 6. / 69 Read more »
COVID-19: 812 health workers infected till date, says FGThe Federal Government on tuesday said not less than 812 health workers have been infected with the COVID-19 virus in the line of duty...
Source: TheNationNews - 🏆 6. / 69 Read more »